Leo Gordon, MD, provides an overview of current treatment strategies currently driven by NCCN guidelines. Leo Gordon, MD: The NCCN [National Comprehensive Cancer Network] is composed of faculty ...

Measures of cell viability and cytotoxicity are essential for the development of new drug treatments for cancer. For a number of years, cell-based assays have been used to assess the impact of drugs ...

Tissue structures are determined by both cell-cell adhesion and cell-matrix adhesion, with the latter describing interactions between cells and the extracellular matrix (ECM). The ECM is the ...

Scientists are developing therapies to eliminate chemotherapy-induced senescent 'zombie' cells, which may fuel inflammation and cancer relapse. These approaches include repurposing existing cancer ...

Lung cancer is classified into two major categories: non-small cell lung cancer (NSCLC), which accounts for 85% of lung cancer cases, and small-cell lung cancer (SCLC), which accounts for the ...

B cells are a type of white blood cell. They make antibodies -- proteins that fight viruses and bacteria. B cells normally can’t cross from your blood into your brain or spinal cord. If you have MS, ...

The purpose of this article is to provide readers with a deeper understanding of the state-of-the-art technology and development surrounding in situ graphene liquid cells-TEM. Image Credit: Tatiana ...

Global CAR T-cell Therapy Market OverviewThe global CAR T-cell therapy market is poised for exceptional growth, with an ...